Shandong Sito Bio-technology Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Shandong Sito Bio-technology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shandong Sito Bio-technology Co Ltd (300583) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.13 Million ≈ $2.21 Million USD) by net assets (CN¥1.80 Billion ≈ $263.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shandong Sito Bio-technology Co Ltd (2012–2025)

Cash flow conversion efficiency of Shandong Sito Bio-technology Co Ltd from 2012 to 2025. This chart illustrates how Shandong Sito Bio-technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Sito Bio-technology Co Ltd stock quote for real-time trading data and today's change.

Shandong Sito Bio-technology Co Ltd Cash Flow Conversion Ratio Explained

Shandong Sito Bio-technology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shandong Sito Bio-technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Sito Bio-technology Co Ltd ranked by their cash flow conversion efficiency. Also see 300583 stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Rana Gruber AS
OL:RANA
0.544x
Planet Technology
TWO:6263
0.091x
Palmer Square Capital BDC Inc.
NYSE:PSBD
0.124x
Gogo Inc
NASDAQ:GOGO
0.208x
Yaxing Chem
SHG:600319
-0.095x
Shenke Slide Bearing Corp
SHE:002633
0.031x
Blend Labs Inc
NYSE:BLND
-0.131x
Transcontinental Inc
TO:TCL-A
-0.095x

Annual Cash Flow Conversion Efficiency for Shandong Sito Bio-technology Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Sito Bio-technology Co Ltd from 2012 to 2025. Review Shandong Sito Bio-technology Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.80 Billion
≈ $262.91 Million
CN¥158.53 Million
≈ $23.20 Million
0.088x -14.51%
2024-12-31 CN¥1.88 Billion
≈ $275.71 Million
CN¥194.46 Million
≈ $28.46 Million
0.103x +329.60%
2023-12-31 CN¥2.07 Billion
≈ $302.24 Million
CN¥-92.85 Million
≈ $-13.59 Million
-0.045x -154.77%
2022-12-31 CN¥1.77 Billion
≈ $259.14 Million
CN¥145.34 Million
≈ $21.27 Million
0.082x -37.48%
2021-12-31 CN¥1.73 Billion
≈ $253.45 Million
CN¥227.35 Million
≈ $33.27 Million
0.131x -12.80%
2020-12-31 CN¥1.69 Billion
≈ $247.50 Million
CN¥254.60 Million
≈ $37.26 Million
0.151x +392.93%
2019-12-31 CN¥1.89 Billion
≈ $276.09 Million
CN¥57.62 Million
≈ $8.43 Million
0.031x +117.00%
2018-12-31 CN¥1.86 Billion
≈ $272.45 Million
CN¥-334.41 Million
≈ $-48.94 Million
-0.180x -2914.08%
2017-12-31 CN¥1.71 Billion
≈ $249.81 Million
CN¥10.90 Million
≈ $1.59 Million
0.006x -95.20%
2016-12-31 CN¥603.01 Million
≈ $88.24 Million
CN¥80.15 Million
≈ $11.73 Million
0.133x -22.69%
2015-12-31 CN¥506.66 Million
≈ $74.14 Million
CN¥87.10 Million
≈ $12.75 Million
0.172x -71.35%
2014-12-31 CN¥290.80 Million
≈ $42.55 Million
CN¥174.49 Million
≈ $25.53 Million
0.600x +137.69%
2013-12-31 CN¥98.83 Million
≈ $14.46 Million
CN¥24.95 Million
≈ $3.65 Million
0.252x +126.87%
2012-12-31 CN¥32.47 Million
≈ $4.75 Million
CN¥-30.50 Million
≈ $-4.46 Million
-0.939x --

About Shandong Sito Bio-technology Co Ltd

SHE:300583 China Biotechnology
Market Cap
$305.91 Million
CN¥2.09 Billion CNY
Market Cap Rank
#14460 Global
#4265 in China
Share Price
CN¥11.02
Change (1 day)
+2.32%
52-Week Range
CN¥10.77 - CN¥16.07
All Time High
CN¥50.68
About

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, bis-decyl alcohol (BA), neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, 16ß and 16… Read more